ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 137 filers reported holding ARRAY BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $65,779,000 | +73.3% | 7,483,416 | +33.1% | 0.01% | +50.0% |
Q3 2016 | $37,956,000 | +103.2% | 5,623,151 | +7.2% | 0.01% | +100.0% |
Q2 2016 | $18,680,000 | +21.8% | 5,247,300 | +0.9% | 0.00% | 0.0% |
Q1 2016 | $15,339,000 | -28.7% | 5,199,679 | +1.9% | 0.00% | -20.0% |
Q4 2015 | $21,523,000 | -11.7% | 5,100,339 | -4.6% | 0.01% | -16.7% |
Q3 2015 | $24,379,000 | -34.6% | 5,346,211 | +3.4% | 0.01% | -33.3% |
Q2 2015 | $37,272,000 | -10.3% | 5,169,481 | -8.3% | 0.01% | -10.0% |
Q1 2015 | $41,532,000 | +72.9% | 5,635,297 | +10.9% | 0.01% | +66.7% |
Q4 2014 | $24,026,000 | +44.8% | 5,079,429 | +9.3% | 0.01% | +20.0% |
Q3 2014 | $16,587,000 | -21.7% | 4,646,266 | -0.0% | 0.01% | -16.7% |
Q2 2014 | $21,188,000 | -9.7% | 4,646,525 | -6.9% | 0.01% | -14.3% |
Q1 2014 | $23,468,000 | -1.7% | 4,993,088 | +4.8% | 0.01% | 0.0% |
Q4 2013 | $23,865,000 | -16.2% | 4,763,543 | +4.1% | 0.01% | -30.0% |
Q3 2013 | $28,463,000 | +57.0% | 4,576,113 | +14.6% | 0.01% | +42.9% |
Q2 2013 | $18,131,000 | – | 3,993,580 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 17,556,586 | $215,946,000 | 10.65% |
BVF INC/IL | 6,402,525 | $78,751,000 | 10.01% |
First Light Asset Management, LLC | 1,469,461 | $18,074,000 | 5.72% |
Avoro Capital Advisors LLC | 5,353,029 | $65,842,000 | 5.11% |
EcoR1 Capital, LLC | 1,250,000 | $15,375,000 | 2.05% |
Cormorant Asset Management, LP | 900,000 | $11,070,000 | 1.96% |
NEXTHERA CAPITAL LP | 615,437 | $7,570,000 | 1.95% |
Monashee Investment Management LLC | 418,000 | $5,141,000 | 1.94% |
Orbimed Advisors | 14,182,900 | $174,450,000 | 1.67% |
KOPP INVESTMENT ADVISORS LLC | 119,579 | $1,471,000 | 1.35% |